A phase 2 trial evaluated the effectiveness and safety of neoadjuvant intravesical mitomycin-C instillation in patients with urothelial non-muscle invasive bladder cancer.

Overall, 5.7 percent of participants with MCI had one-year risk for any indication for anticoagulant and thrombolytic drugs.

Almost all AAV cases were diagnosed in individuals with high pretest probability, including those with renal disease, peripheral neuropathies, or pulmonary infiltrates.

The effects of the extent of lymph node dissection during radical prostatectomy on prostate cancer survival outcomes have been unclear, pending long-term follow-up data from randomized controlled ...

Requirement for prior authorization more common for patients identifying as Black, Hispanic and with non-Medicare insurance.

Increased likelihood seen with high waist circumference and glucose intolerance as well as having two or more cardiometabolic risk factors.

Surveys show health care costs affecting both immediate household stability and longer-term life planning. (HealthDay News) — One-third of Americans are making financial trade-offs to pay for health ...

To shed light on the possible causal link between type 2 diabetes and autoimmune liver disease, a research team led by Jinlong Liu, MD, from the Affiliated Hospital of Chengde Medical University and ...

Use of virtual reality significantly improves patient understanding of and confidence in the shock wave lithotripsy procedure.

A spectrum of nondiabetic kidney diseases is associated with APOL1 high-risk genotypes (G1G1, G1G2, and G2G2), but the M1 variant has been understudied.

Findings from the FIND-CKD trial indicate finerenone may provide a new treatment option for slowing renal function loss in CKD patients without diabetes.

Nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential treatment for adults with systemic lupus erythematosus (SLE). Fast Track designation is designed to ...